Search results for "ANTIBIOTICS"

showing 10 items of 472 documents

Early Development of the Gut Microbiota and Immune Health

2014

In recent years, the increase in human microbiome research brought about by the rapidly evolving “omic” technologies has established that the balance among the microbial groups present in the human gut, and their multipronged interactions with the host, are crucial for health. On the other hand, epidemiological and experimental support has also grown for the ‘early programming hypothesis’, according to which factors that act in utero and early in life program the risks for adverse health outcomes later on. The microbiota of the gut develops during infancy, in close interaction with immune development, and with extensive variability across individuals. It follows that the specific process of…

Microbiology (medical)atopylcsh:MedicineReviewDiseaseinfant gutBiologyGut floraHealth outcomesantibioticsImmune systemHuman gutImmunology and Allergyearly programmingmicrobe-host interactionsMolecular BiologyGut colonizationIntrauterine transmissionnecrotizing enterocolitisgut microbiotaGeneral Immunology and Microbiologylcsh:RHuman microbiomehuman microbiomebiology.organism_classificationintrauterine transmissionInfectious DiseasesImmunologyimmune diseasePathogens
researchProduct

Gut Microbiota Dysbiosis Influences Metabolic Homeostasis in Spodoptera frugiperda

2021

Insect gut microbiota plays important roles in acquiring nutrition, preventing pathogens infection, modulating immune responses, and communicating with environment. Gut microbiota can be affected by external factors such as foods and antibiotics. Spodoptera frugiperda (Lepidoptera: Noctuidae) is an important destructive pest of grain crops worldwide. The function of gut microbiota in S. frugiperda remains to be investigated. In this study, we fed S. frugiperda larvae with artificial diet with antibiotic mixture (penicillin, gentamicin, rifampicin, and streptomycin) to perturb gut microbiota, and then examined the effect of gut microbiota dysbiosis on S. frugiperda gene expression by RNA seq…

Microbiology (medical)autophagyFirmicutesmedicine.drug_classvirusesAntibioticsGut floradigestive systemMicrobiologyantibioticsMicrobiologyActinobacteriaTranscriptomeparasitic diseasesmedicineKEGGOriginal Researchbiologygut microbiotafungiBacteroidetesSpodoptera frugiperdabiology.organism_classificationmedicine.diseaseQR1-502Dysbiosismetabolic homeostasisenergyFrontiers in Microbiology
researchProduct

Antibiotics and Environment.

2020

Since the discovery of penicillin by Alexander Fleming in 1928, the use of antibiotics has become the golden standard in the treatment of bacterial infections of all kinds [...]

Microbiology (medical)endocrine systemmedicine.medical_specialtymedicine.drug_classbusiness.industryanimal diseaseslcsh:RM1-950AntibioticsBiochemistryMicrobiologyAntibiotics antibiotic resistance environmentPenicillinn/alcsh:Therapeutics. PharmacologyInfectious DiseasesAntibiotic resistanceEditorialmedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsIntensive care medicinebusinesshuman activitiesmedicine.drugAntibiotics (Basel, Switzerland)
researchProduct

Unraveling assemblage, functions and stability of the gut microbiota of Blattella germanica by antibiotic treatment

2020

Symbiosis between prokaryotes and eukaryotes is a widespread phenomenon that has contributed to the evolution of eukaryotes. In cockroaches, two types of symbionts coexist: an endosymbiont in the fat body (Blattabacterium), and a rich gut microbiota. The transmission mode of Blattabacterium is vertical, while the gut microbiota of a new generation is mainly formed by bacterial species present in feces. We have carried out a metagenomic analysis of Blattella germanica populations, treated and non-treated with two antibiotics (vancomycin and ampicillin) over two generations to (1) determine the core of bacterial communities and potential functions of the gut microbiota and (2) to gain insight…

Microbiology (medical)functional resiliencePopulationDIVERSITYINSECTSlcsh:QR1-502ZoologyBACTERIAL COMMUNITYGut floraMicrobiologydigestive systemantibioticslcsh:Microbiology03 medical and health sciencesBlattabacteriumSymbiosiseducationFecesOriginal Research030304 developmental biology0303 health scienceseducation.field_of_studyScience & TechnologyendosymbiosisEndosymbiosisbiologygut microbiota030306 microbiologyMIDGUTbiology.organism_classificationVANCOMYCINALIGNMENTCOCKROACHBlattella germanicaMetagenomicsEVOLUTIONARYLife Sciences & BiomedicineBacteriaRESISTANCE
researchProduct

In vitro activity of LY333328, a new glycopeptide, against extracellular and intracellular vancomycin-resistant enterococci.

2000

The objectives of the study were to observe the activity of LY333328, a new semisynthetic glycopeptide, compared to that of vancomycin against six strains of Enterococcus faecium and Enterococcus faecalis, including four vancomycin-resistant strains. Bacteria ingested by polymorphonuclear leukocytes (PMN) as well as extracellular bacteria were studied using a colony count method. The activity against intracellular bacteria was tested with the drugs present in the extracellular medium, as well as after preincubating the PMN and removal of the drugs. LY333328 is active against the tested enterococci, regardless of their susceptibility to vancomycin, with MICs of 1-2 mg/l. It is bacteriostatic…

Microbiology (medical)medicine.drug_classAntibioticsEnterococcus faeciumCell Culture TechniquesMicrobial Sensitivity TestsEnterococcus faecalisMicrobiologymedicineExtracellularEnterococcus faecalisHumansGram-Positive Bacterial InfectionsAntibacterial agentbiologyDose-Response Relationship DrugGlycopeptidesLipoglycopeptidesVancomycin ResistanceGeneral Medicinebiochemical phenomena metabolism and nutritionbiology.organism_classificationStreptococcaceaeGlycopeptideAnti-Bacterial AgentsInfectious DiseasesVancomycinmedicine.drugEnterococcus faeciumInfection
researchProduct

Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review.

2021

Cystic fibrosis (CF) is a genetic disease that causes absence or dysfunction of a protein named transmembrane conductance regulatory protein (CFTR) that works as an anion channel. As a result, the secretions of the organs where CFTR is expressed are very viscous, so their functionality is altered. The main cause of morbidity is due to the involvement of the respiratory system as a result of recurrent respiratory infections by different pathogens. In recent decades, survival has been increasing, rising by around age 50. This is due to the monitoring of patients in multidisciplinary units, early diagnosis with neonatal screening, and advances in treatments. In this chapter, we will approach t…

Microbiology (medical)medicine.drug_classAntibioticsRNA therapyInflammationDiseaseRM1-950ReviewBioinformaticsBiochemistryMicrobiologyCystic fibrosiscystic fibrosis03 medical and health sciences0302 clinical medicineantibioticmedicinePharmacology (medical)030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsRespiratory systemGeneCFTR modulatorRegulation of gene expressiontreatmentbusiness.industrymedicine.diseaseobstructionTransmembrane proteinInfectious Diseases030228 respiratory systeminflammationediting geneTherapeutics. Pharmacologymedicine.symptombusinessgenetic therapyAntibiotics (Basel, Switzerland)
researchProduct

Colonization Resistance of the Gut Microbiota against Clostridium difficile

2015

Antibiotics strongly disrupt the human gut microbiota, which in consequence loses its colonization resistance capacity, allowing infection by opportunistic pathogens such as Clostridium difficile. This bacterium is the main cause of antibiotic-associated diarrhea and a current problem in developed countries, since its incidence and severity have increased during the last years. Furthermore, the emergence of antibiotic resistance strains has reduced the efficiency of the standard treatment with antibiotics, leading to a higher rate of relapses. Here, we review recent efforts focused on the impact of antibiotics in the gut microbiome and their relationship with C. difficile colonization, as w…

Microbiology (medical)medicine.drug_classAntibioticsReviewColonisation resistanceBiologyGut floradigestive systemBiochemistryMicrobiologyantibioticsMicrobiologyAntibiotic resistancecolonization resistancemedicinePharmacology (medical)ColonizationGeneral Pharmacology Toxicology and PharmaceuticsPathogenlcsh:RM1-950Clostridium difficileClostridium difficileAntimicrobialbiology.organism_classificationlcsh:Therapeutics. PharmacologyInfectious Diseasesgut microbiota restorationAntibiotics
researchProduct

Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases …

2013

Antibiotics and antibiotic resistance determinants, natural molecules closely related to bacterial physiology and consistent with an ancient origin, are not only present in antibiotic-producing bacteria. Throughput sequencing technologies have revealed an unexpected reservoir of antibiotic resistance in the environment. These data suggest that co-evolution between antibiotic and antibiotic resistance genes has occurred since the beginning of time. This evolutionary race has probably been slow because of highly regulated processes and low antibiotic concentrations. Therefore to understand this global problem, a new variable must be introduced, that the antibiotic resistance is a natural even…

Microbiology (medical)medicine.drug_classAntibioticslcsh:QR1-502Review ArticleBiologyDiversification (marketing strategy)medicine.disease_causeMicrobiologyEnvironmental resistomelcsh:Microbiologyreview.03 medical and health sciencesPlasmidAntibiotic resistancemedicine030304 developmental biologyOXA-beta-lactamase2. Zero hungerGenetics0303 health sciencesResistance (ecology)030306 microbiologyMechanism (biology)Pathogenic bacteriaβ-lactamase3. Good healthResistomeintrinsic resistomeEvolutionary biologyplasticity-lactamase
researchProduct

Learning From Mistakes: The Role of Phages in Pandemics

2021

The misuse of antibiotics is leading to the emergence of multidrug-resistant (MDR) bacteria, and in the absence of available treatments, this has become a major global threat. In the middle of the recent severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic, which has challenged the whole world, the emergence of MDR bacteria is increasing due to prophylactic administration of antibiotics to intensive care unit patients to prevent secondary bacterial infections. This is just an example underscoring the need to seek alternative treatments against MDR bacteria. To this end, phage therapy has been proposed as a promising tool. However, further research in the field is mandatory to assure…

Microbiology (medical)medicine.medical_specialtyantibiotic resistancephage therapyPhage therapyPhage therapymedicine.drug_classMultidrug-resistant bacteriamedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibioticslcsh:QR1-502multidrug-resistant bacteriaEmergent pathogenMicrobiologylcsh:Microbiologylaw.inventionAntibiotic resistancelawPandemicmedicineIntensive care medicinePublic healthbusiness.industryTreatment regimenPublic healthpublic healthIntensive care unitemergent pathogenPerspectivebusinessFrontiers in Microbiology
researchProduct

Empiric Antibiotics in Hospitalized Pneumonia: Discontinuation Is Better than De-escalation

2021

Microbiology (medical)medicine.medical_specialtybusiness.industrymedicine.drug_classAntibioticsMEDLINEmedicine.diseaseDiscontinuationPneumoniaInfectious DiseasesMedicinebusinessIntensive care medicineDe-escalationClinical Infectious Diseases
researchProduct